Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>
| Cat. No. | Species | Product Description | Structure | Purity | Feature |
|---|---|---|---|---|---|
| SEP-H5255 | Human | Human P-Selectin / CD62P Protein, Fc Tag |  |
|
|
| SEP-H52E4 | Human | Human P-Selectin / CD62P Protein, His Tag |  |
|
| Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
|---|---|---|---|---|---|---|---|---|---|---|
| Crizanlizumab | Sel-G-1; SEG-101; Sel-G1 | Approved | Novartis Pharma Ag, Selexys | Adakveo | EU | Anemia, Sickle Cell | Novartis Europharm Ltd | 2019-11-15 | Coronavirus Disease 2019 (COVID-19); Leukoencephalopathies; Primary Myelofibrosis; Priapism; Anemia, Sickle Cell | Details |
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| Inclacumab | RG-1512; RO-4905417; LC-1004-002; DSM-ACC-2641; R-1512 | Phase 3 Clinical | F. Hoffmann-La Roche Ltd, Genmab A/S | Pain; Myocardial Infarction; Graft Occlusion, Vascular; Anemia, Sickle Cell; Peripheral Arterial Disease | Details |
| Dociparstat sodium | ODSH; CX-01; PGX-100; PGX-ODSH-2013-AML-1 | Phase 3 Clinical | Paringenix | Coronavirus Disease 2019 (COVID-19); Pancreatic Neoplasms; Myeloproliferative Disorders; Myelodysplastic Syndromes; Leukemia, Myeloid, Acute; Pulmonary Disease, Chronic Obstructive; Protein-Losing Enteropathies; Acute Lung Injury | Details |
This web search service is supported by Google Inc.
A-Z
